Preliminary efficacy and safety of Relmacabtagene autoleucel (Carteyva) in adults with relapsed/refractory follicular lymphoma in China: A phase I/II clinical trial

Ying, ZT; Zou, DH; Yang, HY; Wu, JQ; Guo, Y; Li, WY; Liu, H; Wang, C; Ma, L; Yang, S; Zhou, ZS; Qin, Y; Song, YQ; Zhu, J

Song, YQ; Zhu, J (通讯作者),Peking Univ Canc Hosp & Inst, Dept Lymphoma, Key Lab Carcinogenesis & Translat Res, Minist Educ Beijing, 52 Fucheng Rd, Beijing 100142, Peoples R China.

AMERICAN JOURNAL OF HEMATOLOGY, 2022; 97 (12): E436